The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/10071170
Conclusion of this study
Symptoms generally improved with time but not significantly and there were no significant differences between the treatment and placebo groups. Pretreatment red-cell membrane (RBC) lipids of patients compared with age-and sex-matched normal controls showed no significant differences.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study